Article

Patients with mixed astigmatism achieve good results after refractive treatment

Houston—The CustomVue refractive treatment (VISX/AMO) for patients with mixed astigmatism demonstrated good results at 6 months, according to Douglas D. Koch, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Jason Bacharach, MD, on early-onset efficacy with perfluorohexyloctane in dry eye
© 2025 MJH Life Sciences

All rights reserved.